Clinical utility of bone marrow flow cytometry in B-cell non-Hodgkin lymphomas (B-NHL)

Histopathology

Volumn 45, Issue 3, 2004, Pages 268-274

  Perea, G ^a   Altes A ^a   Bellido, M ^a   Aventin A ^a   Bordes, R ^a   Ayats, R ^a   Remacha, A F ^a   Espinosa, I ^a   Briones, J ^a   Sierra, J ^a   Nomdedéu, Josep F ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Bone marrow; Flow cytometry; Follicular lymphoma; Prognosis

Indexed keywords

ARTICLE; B CELL LYMPHOMA; BONE MARROW BIOPSY; BONE MARROW CELL; BURKITT LYMPHOMA; CELL STRUCTURE; CHRONIC LYMPHATIC LEUKEMIA; CLONAL VARIATION; CONTROLLED STUDY; FLOW CYTOMETRY; FOLLICULAR CARCINOMA; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; T CELL LYMPHOMA; VALIDATION PROCESS;

BONE MARROW; DISEASE-FREE SURVIVAL; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; MULTIVARIATE ANALYSIS; PROGNOSIS;

EID: 4644255480     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2004.01937.x     Document Type: Article

References (21)

1. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphomas. Blood 1997; 89; 3909-3918.
2. Tbakhi A, Edinger M. Myles J, Pahlman B, Tubbs RR. Flow cytometric immunophenotyping of non-Hodgkin's lymphomas and related disorders. Cytometry 1996; 25; 113-124.
3. Picker LJ, Weiss LM, Medeiros LJ, Wood GS, Warnken RA. Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. Am. J. Pathol. 1987; 128; 181-201.
4. Darrell C, Foon KA. Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy. Blood 1997; 90; 2863-2892.
5. General Haematology Task Force of BCSH. Immunophenotyping in the diagnosis of chronic lymphoproliferative disorders. J. Clin. Pathol. 1994; 47; 871-875.
6. Naughton MJ, Hess JL, Zutter MM, Bartlett NL. Bone marrow staging in patients with non-Hodgkin's lymphoma. Is flow cytometry a useful test? Cancer 1998; 82; 1154-1159.
7. Dunphy CH. Combining morphology and flow cytometric immunophenotyping to evaluate bone marrow specimens for B-cell malignant neoplasm. Am. J. Clin. Pathol. 1998; 109; 625-630.
8. Hanson CA, Kurtin PJ, Katzmann JA et al. Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphoma. Blood 1999; 94; 3889-3896.
9. Duggan PR, Easton D, Luider J, Auer IA. Bone marrow staging of patients with non Hodgkin's lymphoma by flow cytometry. Correlation with morphology. Cancer 2000; 88; 894-899.
10. Palacio C, Acebedo G, Navarrete M et al. Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas. Haematologica 2001; 86; 934-940.
11. Jaffe ES, Harris NL, Stein H, Vardiman JW. Tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001.
12. Wells DA, Hall MC, Shulman HM, Loken MR. Occult B cell malignancies can be detected by three-color flow cytometry in patients with cytopenias. Leukemia 1998: 12; 2015-2023.
13. Yan Y, Chan WC, Weisenburger DD et al. Clinical and prognostic significance of bone marrow involvement in patients with diffuse agressive B-cell lymphoma. J. Clin. Oncol. 1995; 13; 1336-1342.
14. Pittaluga S, Tierens A, Dodoo YL, Delabie J, De Wolf-Peeters C. How reliable is histologic examination of bone marrow trephine biopsy specimens for the staging on non-Hodgkin lymphoma? A study of hairy cell leukemia and mantle cell lymphoma involvement of the bone marrow trephine specimen by histologic, immunohistochemical, and polymerase chain reaction techniques. Am. J. Clin. Pathol. 1999; 111; 179-184.
15. Cheson BD, Horning SJ, Coiffier B et al. Report of an International Workshop to standarize response criteria for non-Hodgkin's lymphoma. J. Clin. Oncol. 1999; 17; 1244-1253.
16. Juneja SK, Wolf MM, Cooper IA. Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma. J. Clin. Pathol. 1990; 43; 630-632.
17. Fineberg S, Marsh E, Alfonso F et al. Immunophenotypic evaluation of the bone marrow in non-Hodgkin's lymphoma. Hum. Pathol. 1993; 24; 636-642.
18. Kaleem Z, Zehnbauer BA, White G, Zutter MM. Lack of expression of surface immunoglobulin light chains in B-cell non-Hodgkin lymphomas. Am. J. Clin. Pathol. 2000; 113; 399-405.
19. Sandhaus LM, Voelkerding KV, Dougherty J, Raska K Jr. Combined utility of gene rearrangement analysis and FC in the diagnosis of lymphoproliferative disease in the bone marrow. Hematol. Pathol. 1990; 4; 135-148.
20. Denes AE, Hathaway C. Cost benefit analysis of bone marrow immunophenotyping in non Hodgkin's lymphoma. Proc. Am. Soc. Clin. Oncol. 1994; 13; 291.
21. Crotty PL, Smith BR, Tallini G. Morphologic, immunophenotypic, and molecular evaluation of bone marrow involvement in non-Hodgkin's lymphoma. Diagn. Mol. Pathol. 1998; 7; 90-95.